Pharmacokinetic and pharmacodynamic interaction of vildagliptin and voglibose in Japanese patients with Type 2 diabetes

维尔达格利普汀 2型糖尿病 医学 二肽基肽酶-4抑制剂 药理学 内科学 内分泌学 二肽基肽酶-4 药效学 药代动力学 糖尿病 交叉研究 肠促胰岛素 安慰剂 病理 替代医学
作者
Masayuki Yamaguchi,Takami Saji,Sachiko Mita,Kenneth Kulmatycki,Yan‐Ling He,Kenichi Furihata,Kazuki Sekiguchi
出处
期刊:International Journal of Clinical Pharmacology and Therapeutics [Dustri-Verlag Dr. Karl Feistle]
卷期号:51 (08): 641-651 被引量:13
标识
DOI:10.5414/cp201902
摘要

To assess the extent of pharmacokinetic and pharmacodynamic interaction between vildagliptin, a potent and selective inhibitor of dipeptidyl peptidase IV (DPP-4) enzyme, and voglibose, an α-glucosidase inhibitor widely prescribed in Japan, when coadministered in Japanese patients with Type 2 diabetes.In this open-label, randomized, 3-treatment, 3-period and 6-way crossover study, 24 Japanese patients with Type 2 diabetes received 50 mg vildagliptin twice daily; 50 mg vildagliptin twice daily co-administered with 0.2 mg voglibose three times daily; or 0.2 mg voglibose three times daily for 3 days in each period. Plasma concentrations of vildagliptin, DPP-4, glucagon-like peptide-1 (GLP-1), glucose, insulin, and glucagon were determined from blood samples collected at steady state.Exposure to vildagliptin 50 mg (area under the concentration-time curve from 0 to 12 hours (AUCτ,ss)) and maximum plasma concentration at steady state (Cmax,ss) was reduced by 23% and 34% respectively with co-administration of voglibose. The percentage of DPP-4 inhibition by vildagliptin remained unchanged when vildagliptin was given alone or co-administered with voglibose; maximum inhibition was 98.3 ± 1.4% (mean ± SD) for vildagliptin alone and 97.4 ± 1.1% with co-administration. Coadministration of vildagliptin and voglibose led to a greater increase in the active GLP-1 plasma concentration than did vildagliptin alone (geometric mean ratio 1.63 (90% CI, 1.30, 2.03), p = 0.0007). The combination of vildagliptin and voglibose also led to a significantly lower plasma glucose levels (p < 0.0001).Plasma vildagliptin levels were decreased when voglibose was co-administered, although DPP- 4 inhibition remained unchanged. Co-administration led to significantly better pharmacodynamic response compared with each treatment alone, including higher active GLP-1 and lower glucose levels. The results indicate that this coadministration may be beneficial in the clinical situation. Vildagliptin and voglibose treatments, alone or when co-administered, were well tolerated in Japanese patients with Type 2 diabetes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Beta2187发布了新的文献求助10
刚刚
yayayang发布了新的文献求助10
刚刚
Cupid完成签到,获得积分10
1秒前
orixero应助领会采纳,获得10
2秒前
顾矜应助领会采纳,获得10
2秒前
fiber完成签到,获得积分20
3秒前
4秒前
4秒前
FashionBoy应助我不转弯采纳,获得10
4秒前
pos完成签到,获得积分20
6秒前
慕青应助Sharyn227采纳,获得10
6秒前
狗蛋发布了新的文献求助10
8秒前
8秒前
风登楼发布了新的文献求助10
9秒前
10秒前
pluto应助侧耳倾听采纳,获得10
11秒前
11秒前
11秒前
黄卡卡应助侧耳倾听采纳,获得10
11秒前
11秒前
盛夏如花发布了新的文献求助10
11秒前
外向的向梦完成签到,获得积分10
11秒前
赘婿应助平常竹采纳,获得10
12秒前
13秒前
fiber发布了新的文献求助10
14秒前
14秒前
FashionBoy应助萌酱采纳,获得10
15秒前
16秒前
Singularity发布了新的文献求助10
19秒前
21秒前
22秒前
神秘完成签到 ,获得积分10
23秒前
善学以致用应助粗心的邴采纳,获得10
24秒前
24秒前
SY完成签到,获得积分10
25秒前
25秒前
PU应助iTaciturne采纳,获得10
26秒前
小戎要天天开心完成签到,获得积分10
27秒前
苍刺发布了新的文献求助10
27秒前
ho完成签到,获得积分10
27秒前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Semiconductor Process Reliability in Practice 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 600
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3234215
求助须知:如何正确求助?哪些是违规求助? 2880628
关于积分的说明 8216267
捐赠科研通 2548212
什么是DOI,文献DOI怎么找? 1377613
科研通“疑难数据库(出版商)”最低求助积分说明 647925
邀请新用户注册赠送积分活动 623302